Parenteral ascorbic acid as a key for regulating microcirculation in critically ill.
Biesalski
Hans Konrad
HK
D000818:Animals; D000975:Antioxidants / Q000378:metabolism / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D003422:Critical Care; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000378:metabolism; D051379:Mice; D008833:Microcirculation / Q000187:drug effects*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism* / Q000502:physiology; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D018805:Sepsis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism
D000975:Antioxidants; D052250:Nitric Oxide Synthase Type III; D001205:Ascorbic Acid